Marietta Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Marietta Wealth Management's BMY Position: Q1 2026 in Review
Marietta Wealth Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 7,362 shares worth $446K. The stake represents 0.05% of the portfolio and ranks #113 among its holdings. This is a return to the name: Marietta Wealth Management previously reported a position in BMY as recently as Q3 2021.
Marietta Wealth Management first reported a position in BMY in Q1 2019 and has held it in 12 quarters since. The position peaked at $3.62M in Q1 2021. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Marietta Wealth Management held 7,362 shares of Bristol-Myers Squibb worth $446K as of Q1 2026.
- Bristol-Myers Squibb was a new Marietta Wealth Management position in Q1 2026.
- Bristol-Myers Squibb made up 0.05% of Marietta Wealth Management's portfolio in Q1 2026, its #113 holding.
- Marietta Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 12 quarters since.
- Marietta Wealth Management's Bristol-Myers Squibb position peaked at $3.62M in Q1 2021.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Marietta Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.